Vergoeding 2018-2022 voor ATC-subgroep J05AR18 : Emtricitabine tenofovir alafenamide elvitegravir cobicista
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
|
J05AR18 Emtricitabine tenofovir alafenamide elvitegravir cobicista (
Genvoya ®)
|
33.761.900 | 31.923.000 | 27.966.100 | 23.652.300 | 21.655.000 |
| Totaal | 33.761.900 | 31.923.000 | 27.966.100 | 23.652.300 | 21.655.000 |